In depth profiling of human iPSC cardiomyocytes: from electrophysiology to phenotypic assays

Authors

Saïd El Haou, Senior Scientist, Metrion Biosciences

Overview

In depth profiling of human iPSC cardiomyocytes: From electrophysiology to phenotypic assays. Saïd El Haou’s presentation covers the topics of Manual Patch Clamp – Current Clamp, Axion Maestro – MEA and the Nanion CardioExcyte96 – Impedance.

Please contact us if you would like any further information regarding our suite of cardiac safety services.

Background

Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative is a regulatory proposal sponsored by US, European and Japanese safety bodies to replace/augment current cardiac safety testing regimes.

Saïd El Haou’s presentation covers the topics of Manual Patch Clamp (Current Clamp), the Axion Maestro (MEA) and the Nanion CardioExcyte96 (Impedance) and their use to better assess risk earlier in the drug discovery process. This is in addition to the use of in vitro data for in silico modelling of arrhythmia and Torsade de Pointe (TdP) risk and the confirmation of proarrhythmia and TdP signals in human cardiomyocytes.

Saïd gave the presentation at the Ncardia Workshop, Cologne, 29th November – 1st December 2017.

Download
Recommended Publications
Latest Publications
Metrion Biosciences

Let’s work together

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.
Contact us for a quote or discussion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram